In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II

AIDS Research and Human Retroviruses

Volumn 16, Issue 16, 2000, Pages 1757-1764

  Lairmore, M D ^a,b   Albrecht, B ^a   D'Souza, C ^a   Nisbet, J W ^a   Ding, W ^a   Bartoe, J T ^a   Green, P L ^a,b   Zhang, W ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; NUCLEAR PROTEIN; PROTEIN P13; PROTEIN P30; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HELA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RABBIT; SEQUENCE HOMOLOGY; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALS; CELL TRANSFORMATION, VIRAL; GENES, PX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; RABBITS; RETROVIRIDAE PROTEINS; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 0034331210     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050193272     Document Type: Article

References (55)

1. Multiple targets of HTLV-1 for dysregulation of host cells
2. Human T cell lymphotropic retroviruses: Assocition with diseases of the nervous system
3. Retroviruses-human T-cell lymphotropic virus
4. Human T cell leukemia virus type I (HTLV-1) and human diseases
5. HTLV-1 uveitis: A distinct clinical entity caused by HTLV-1
6. HTLV-1 and polymyositis in Jamaica
7. Detection of HTLV-1 proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy
8. Human T-cell lymphotropic virus type 1-associated myelopathy, Sjogren syndrome and lymphocytic pneumonitis
9. HTLV-1 polymyositis in a patient also infected with HIV
10. Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type I infection
11. A human suppressor of c-Jun N-terminal kinase 1 activation by tumor necrosis factor alpha
12. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I
13. Molecular features of the human T-cell leukemia virus: Mechanisms of transformation and leukemogenicity
14. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I
15. Expression of altneratively spliced human T-cell lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia and healthy carriers
16. Protein isoforms encoded by the pX region of the human T-cell leukemia virus type I
17. Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines
18. Evidence for the chronic in vivo production of human T cell leukemia virus type 1 Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides
19. 1 protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase
20. The p12, p13 and p30 proteins encoded by human T-cell leukemia/lymphotropic virus type-1 open reading frames I and II are localized in three different cellular compartments
21. 1 and the vacuolar H+-AT-Pase 16 kDa subunit protein
22. The human T-cell leukemia/lymphotropic virus type 1 p12(I) protein binds the interleukin-2 receptor beta and gamma(c) chains and affects their expression on the cell surface
23. Selective ablation of human T-lymphotropic virus type 1 p12 reduces viral infectivity in vivo
24. Mitochondrial targeting of the p13(II) protein coded by the x-II ORF of human T-cell leukemia/lymphotopic virus type 1 (HTLV- 1)
25. The HTLV-1 p12I, p30II, and p13II proteins are dispensible for the immortalization of primary lymphocytes
26. Functional role of pX ORF II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo
27. Construction and characterization of infectious human T-cell leukemia virus type I molecular clones
28. In vitro CD4(+) lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1
29. Proliferation response to IL-2 and Jak/State activation of T-cells immortalized by human T-lymphotropic virus type 1 is independent of open reading frame I expression
30. Lymphocytes activation and effector functions: The role of cell surface molecules
31. The interleukin 2 receptor γ chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
32. Protein modules and signaling networks
33. Identification of a nef allele that causes lymphocytic activation and acute disease in macaque monkeys
34. Proline-rich (PXXP) motifs in HTLV-1 Nef binds to SH3 domains of a subset of src kinases and are required for the enhanced growth of Nef+ viruses by not for downregulation of CD4
35. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes
36. Molecular determinants of Nef function
37. The importance of Nef in the induction of human immunodeficiency type I replication from primary quiescent CD4 lymphocytes
38. Activation of the ser-family tyrosine kinase Hck by SH3 domain replacement
39. Importance of the nef gene for maintenance of high viral loads and for the development of AIDS
40. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene
41. Requirements for lymphocytic activation by unusual strains of simian immunodeficiency virus
42. A role of natural SIV and HIV type 1 Nef alleles in lymphocyte activation
43. Experimental infection of rabbits with human T-cell leukemia virus type 1
44. Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease
45. Protection of Cynomolgus monkeys against infection by HTLV-1 by immunization with viral env gene products produced in E. coli
46. Infection of rats with HTLV-1: Susceptibility of inbred strains, antibody response and provirus location
47. Potential role of natural killer cells in controlling tumorigenesis of human T-cell leukemia viruses
48. Development of leukemia in mice transgenic for the tax gene of HTLV-1
49. Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46
50. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction
51. Persistent infection of rabbits with HTLV-I: Patterns of anti-viral reactivity and detection of virus by gene amplification
52. Induction of antibody responses that neutralize HTLV-1 infection in vitro and in vivo by peptide immunization
53. A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo
54. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein
55. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames